Welcome to the AstraZeneca rosuvastatin clinical information web site
The intention of this web site is to provide a comprehensive, scientific, non-promotional summary of rosuvastatin clinical trials conducted by AstraZeneca and a summary of post marketing data for the first five years that rosuvastatin was available. Acceptance of the following AstraZeneca terms and conditions will enable you to view the rosuvastatin clinical trial information. The site will not be updated beyond April 2008.
You have chosen not to accept the disclaimer notice and we can therefor not give you access to rosuvastatininformation.com.
Please visit our corporate website for information about AstraZeneca www.astrazeneca.com
